Aerovate Therapeutics (AVTE) Q4 2023 Earnings

25MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.74
-0.49
-0.25
0

Details

Expected EPS
-0.678883
Actual EPS
-0.74
Surprise EPS
-0.06
Surprise Percent
+9%

Description

Aerovate Therapeutics (AVTE) has reported earnings of -0.74 per share for Q4 2023.

0 Comments

Share your thoughts